The ROE (Return on Equity) of Bioscience Neutraceuticals Inc (DEVV) is 256.43%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
Date | Value |
---|---|
2019-12-31 | 256.43% |
2018-12-31 | 39.68% |
2017-12-31 | 115.28% |
2016-12-31 | 53.80% |
2015-12-31 | -100.00% |